Norbert G. Riedel, Ph.D.
Executive Chairman of the Board
Patrick Enright
Lead Independent Director
Founder and Managing Director, Longitude Capital
Henry O. Gosebruch
Executive Vice President and Chief Strategy Officer, AbbVie Inc.
Terry P. Gould
Partner and Head of Venture / Growth Equity Investments, Adams Street Partners
Robert J. Hombach
Retired CFO, Baxter International Inc. and Baxalta Inc.
Andy Kidd, M.D.
President & CEO, Aptinyx
Adam M. Koppel, M.D., Ph.D.
Managing Director, Bain Capital Life Sciences
Joan W. Miller, M.D.
David Glendenning Cogan Professor of Ophthalmology and Chair of the Department of Ophthalmology, Harvard Medical School
Chief of Ophthalmology, Massachusetts Eye and Ear and Massachusetts General Hospital
Gilmore O’Neill, M.B., M.M.Sc.
Former Executive Vice President of Research and Development and Chief Medical Officer, Sarepta Therapeutics
Former Senior Vice President, Late Stage Clinical Development, Biogen
Rachel Sherman, M.D., M.P.H.
Retired Principal Deputy Commissioner of FDA